Central Giant Cell Granuloma of the Mandible: A Case Report
Author(s) -
Babacar Tamba,
Mouhammad Kane,
Mamadou Diatta,
Bintou Cathérine Gassama,
Alpha Kounta,
Abdou Ba,
Ndèye Fatou Kébé,
Soukèye Dia Tine
Publication year - 2020
Publication title -
international journal of clinical oral and maxillofacial surgery
Language(s) - English
Resource type - Journals
eISSN - 2472-1344
pISSN - 2472-1336
DOI - 10.11648/j.ijcoms.20200602.14
Subject(s) - central giant cell granuloma , medicine , mandible (arthropod mouthpart) , giant cell , asymptomatic , coronal plane , sagittal plane , granuloma , surgery , pathology , anatomy , biology , botany , genus
The central giant cell granuloma (CGCG) of the jaws is a rare benign tumour of the mandible (lower jaw) and the maxilla (upper jaw) characterized by destruction of the bone, loss of symmetry of the face and displacement of teeth and tooth germs, especially in younger patients. It is asymptomatic and present with slow growth often accompanied by dental mobility. The removal of this tumour is mutilating and is followed prosthetic rehabilitation. The aim of this study was to report a case of central giant cell granuloma localizated to the symphyseal region in a young patient. The case reported is that of a 14-year-old girl who received a consultation for a tumor in the symphysical region causing an aesthetic impact. The tumor was firm, painless and had been developing for about a year. The cortical were broken in places, in transverse, sagittal and coronal sections. The treatment consisted of her excision under general anesthesia causing a significant loss of substance. The tumor mass, very hemorrhagic, was extended to the buccal floor. At the end of the intervention, a significant loss of substance was observed. Two months later, a partial adjunct prosthesis was performed. The anatomo-pathological examination showed of several multinucleated giant cells, a few histiocytes, lymphocytes and fibroblasts. The removal of this aggressive tumour remains mutilating, with significant psychological repercussions. More recently, antiangiogenic therapy with interferon alpha has been successfully applied.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom